BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$71 | -$64 | -$40 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $3 | $3 |
| Change in WC | $11 | $7 | $1 |
| Other Non-Cash | $1 | $17 | $0 |
| Operating Cash Flow | -$52 | -$37 | -$36 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – |
| Debt Repay. | -$6 | $35 | $3 |
| Stock Issued | $222 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $166 | -$0 | -$0 |
| Financing Cash Flow | $381 | $35 | $2 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $329 | -$3 | -$34 |
| Supplemental Information | – | – | – |
| Beg. Cash | $25 | $28 | $61 |
| End Cash | $354 | $25 | $28 |
| Free Cash Flow | -$52 | -$38 | -$36 |